Operating Lease, Right-of-Use Asset in USD of PLUS THERAPEUTICS, INC. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PLUS THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $20K, a 81.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $20K -$86K -81.1% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $29K -$110K -79.1% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $38K -$133K -77.8% 31 Mar 2025 10-Q 30 May 2025
Q4 2024 $73K -$129K -63.9% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $106K -$126K -54.3% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $139K -$103K -42.6% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $171K -$99K -36.7% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $202K -$46K -18.5% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $232K -$43K -15.6% 30 Sep 2023 10-Q 31 Oct 2023
Q2 2023 $242K -$61K -20.1% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $270K -$46K -14.6% 31 Mar 2023 10-Q 20 Apr 2023
Q4 2022 $248K -$93K -27.3% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $275K -$284K -50.8% 30 Sep 2022 10-Q 20 Oct 2022
Q2 2022 $303K -$335K -52.5% 30 Jun 2022 10-Q 21 Jul 2022
Q1 2022 $316K -$284K -47.3% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 $341K -$295K -46.4% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $559K -$112K -16.7% 30 Sep 2021 10-Q 21 Oct 2021
Q2 2021 $638K -$69K -9.76% 30 Jun 2021 10-Q 22 Jul 2021
Q1 2021 $600K -$144K -19.4% 31 Mar 2021 10-Q 22 Apr 2021
Q4 2020 $636K -$145K -18.6% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $671K -$147K -18% 30 Sep 2020 10-Q 22 Oct 2020
Q2 2020 $707K -$198K -21.9% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $744K -$379K -33.7% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $781K 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 $818K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $905K 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 $1.12M 31 Mar 2019 8-K 10 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.